Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6528
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration ; volume:11 ; number:1 ; day:19 ; month:12 ; year:2021 ; pages:377-386 ; date:2.2022
Ophthalmology and therapy ; 11, Heft 1 (19.12.2021), 377-386, 2.2022
- Creator
-
Arrigo, Alessandro
Amato, Alessia
Barresi, Costanza
Aragona, Emanuela
Saladino, Andrea
Pina, Adelaide
Calcagno, Francesca
Bandello, Francesco
Battaglia Parodi, Maurizio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-021-00443-1
- URN
-
urn:nbn:de:101:1-2022050109132208503135
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Arrigo, Alessandro
- Amato, Alessia
- Barresi, Costanza
- Aragona, Emanuela
- Saladino, Andrea
- Pina, Adelaide
- Calcagno, Francesca
- Bandello, Francesco
- Battaglia Parodi, Maurizio
- SpringerLink (Online service)
Other Objects (12)
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Prediction of activity in eyes with macular neovascularization due to age-related macular degeneration using deep learning
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Prediction of activity in eyes with macular neovascularization due to age-related macular degeneration using deep learning
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration